Cancer-related post-treatment pain and its impact on treatment satisfaction with medication in women with breast cancer: a cross-sectional study from Palestine.
Biological therapy
Breast cancer
Chemotherapy
Hormonal therapy
Patient satisfaction with medication
Posttreatment pain
Side effects
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
07 Aug 2023
07 Aug 2023
Historique:
received:
23
02
2023
accepted:
31
07
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Pain after therapy is an important clinical problem in patients with breast cancer. Unfortunately, cancer patients have a lower quality of life due to inadequate treatment of posttreatment pain; therefore, improving medication management plans and palliative care has become one of the most important targets of cancer therapy. Therefore, the current study aimed to examine the impact of posttreatment pain on medication satisfaction in patients with various stages of breast cancer in Palestine. A cross-sectional analytical study was conducted et al.-Watani Hospital and An-Najah National University Hospital in the Nablus area. Using the Brief Pain Inventory (BPI), the intensity and interference of pain were evaluated. In addition, patients' satisfaction with cancer management medications was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM). Two hundred fifty-four patients were included in this study. All were women, with a mean ± SD age of 53.1 ± 10.7 years. The median score for pain severity was 7.0. Pain in the lower extremities was the most reported location. There was a negative association between the global satisfaction domain and the presence of posttreatment pain (p < 0.001). Furthermore, significant differences and negative correlations were found between global satisfaction and posttreatment pain on the day of the interview (p = 0.001), pain medication (p < 0.001), paracetamol use (p < 0.001), and the presence of side effects (p = 0.003). There were significant negative correlations (p < 0.05) between pain severity and interference with effectiveness (r = -0.258, -0.319, respectively), side effects (r = -0.414, -0.514, respectively), convenience (r = -0.274, -0.307, respectively), and global satisfaction domain scores (r = -0.293, -0.287, respectively). Exposure to chemotherapy was the only significant positive correlation with global satisfaction (p = 0.007). The regression analysis results indicated an independent association between chemotherapy use and a higher global satisfaction score (p = 0.011). Patients with posttreatment pain, side effects, and greater interference of pain with their functioning had lower satisfaction scores. Therefore, better management of their treatment medications, side effects, and pain medications is recommended to enhance their satisfaction and quality of life. Several aspects of palliative care should be organized to improve the patient's satisfaction and quality of life in addition to conducting longitudinal studies to evaluate the pain and satisfaction of different types of cancers.
Sections du résumé
BACKGROUND
BACKGROUND
Pain after therapy is an important clinical problem in patients with breast cancer. Unfortunately, cancer patients have a lower quality of life due to inadequate treatment of posttreatment pain; therefore, improving medication management plans and palliative care has become one of the most important targets of cancer therapy. Therefore, the current study aimed to examine the impact of posttreatment pain on medication satisfaction in patients with various stages of breast cancer in Palestine.
METHODS
METHODS
A cross-sectional analytical study was conducted et al.-Watani Hospital and An-Najah National University Hospital in the Nablus area. Using the Brief Pain Inventory (BPI), the intensity and interference of pain were evaluated. In addition, patients' satisfaction with cancer management medications was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM).
RESULTS
RESULTS
Two hundred fifty-four patients were included in this study. All were women, with a mean ± SD age of 53.1 ± 10.7 years. The median score for pain severity was 7.0. Pain in the lower extremities was the most reported location. There was a negative association between the global satisfaction domain and the presence of posttreatment pain (p < 0.001). Furthermore, significant differences and negative correlations were found between global satisfaction and posttreatment pain on the day of the interview (p = 0.001), pain medication (p < 0.001), paracetamol use (p < 0.001), and the presence of side effects (p = 0.003). There were significant negative correlations (p < 0.05) between pain severity and interference with effectiveness (r = -0.258, -0.319, respectively), side effects (r = -0.414, -0.514, respectively), convenience (r = -0.274, -0.307, respectively), and global satisfaction domain scores (r = -0.293, -0.287, respectively). Exposure to chemotherapy was the only significant positive correlation with global satisfaction (p = 0.007). The regression analysis results indicated an independent association between chemotherapy use and a higher global satisfaction score (p = 0.011).
CONCLUSIONS
CONCLUSIONS
Patients with posttreatment pain, side effects, and greater interference of pain with their functioning had lower satisfaction scores. Therefore, better management of their treatment medications, side effects, and pain medications is recommended to enhance their satisfaction and quality of life. Several aspects of palliative care should be organized to improve the patient's satisfaction and quality of life in addition to conducting longitudinal studies to evaluate the pain and satisfaction of different types of cancers.
Identifiants
pubmed: 37548711
doi: 10.1007/s00520-023-07981-3
pii: 10.1007/s00520-023-07981-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
509Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Stewart BW, Kleihues P (2003) International Agency for Research on Cancer, World Health Organization. World Cancer Report 2003: World Cancer Reports. https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2003 . Accessed 2 Jan 2023
Peretti-Watel P, Bendiane MK, Spica L, Rey D (2012) Pain narratives in breast cancer survivors. Pain Res Treat 2012:153060
pubmed: 23150819
pmcid: 3488421
Ministry of Health, Palestinian Health Information Center (2019) Health Annual Report, Palestine 2018. https://site.moh.ps/Content/Books/fE4zsafxsjNVhJntidJnqnnEHUibMuC1NYu66TNEmoNUJ1ZxeRcCm3_Iei1j8d4YesYKxRyEhD6PZqdxzBa4z91pIhALGXoDGEhlEIPai9X9O.pdf . Accessed 3 Jan 2020
Ministry of Health, Palestinian Health Information Center (2017) Health Annual Report 2016: Palestine. https://site.moh.ps/Content/Books/ZxRcynmiUofNqt66u4CrHRgmJR6Uv7z77srjjIEAho6xnz5V3rgLTu_RhO7xf2j2VusNiIvWkjwp84yXHLdGleB97gKrHHI5iZ9oPJ25owGEN.pdf . Accessed 3 Jan 2020
Ministry of Health, Palestinian Health Information Center (2021) Health Annual Report 2020: Palestine. https://site.moh.ps/Content/Books/chup6JkjmKecG8zGx6hnXjILuGecGmPq7Bt4Q4HsFj6vv7tW2W4aGE_ZiCEqSMuZx7v6kHVcDAjC59QDCVuSXx3NmUfwX6Ciqm4OxQrB4xAE6.pdf . Accessed 3 Jan 2020
Elshami M, Usrof FD, Alser M, Al-Slaibi I, Okshiya HM, Ghithan RJ, Shurrab NRS, Ismail IO, Mahfouz II, Fannon AA (2022) Awareness of Palestinian Women About Breast Cancer Risk Factors: A National Cross-Sectional Study. JCO Glob Oncol 8:e2200087
pubmed: 36508704
pmcid: 10166356
doi: 10.1200/GO.22.00087
Diaconu C, Pantis C, Cirimbei C, Bordea C, Gruia MI, Blidaru A (2015) Pain-associated biomarkers in breast cancer. J Med Life 8(1):32–36
pubmed: 25914735
pmcid: 4397516
Groenvold M (2010) Health-related quality of life in early breast cancer. Dan Med Bull 57(9):B4184
pubmed: 20816024
Andersen KG, Kehlet H (2011) Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 12(7):725–746
pubmed: 21435953
doi: 10.1016/j.jpain.2010.12.005
Gulluoglu BM, Cingi A, Cakir T, Gercek A, Barlas A, Eti Z (2006) Factors related to post-treatment chronic pain in breast cancer survivors: the interference of pain with life functions. Int J Fertil Womens Med 51(2):75–82
pubmed: 16881383
Thronæs M, Balstad TR, Brunelli C, Løhre ET, Klepstad P, Vagnildhaug OM, Kaasa S, Knudsen AK, Solheim TS (2020) Pain management index (PMI)—does it reflect cancer patients’ wish for focus on pain? Support Care Cancer 28:1675–1684
pubmed: 31290020
doi: 10.1007/s00520-019-04981-0
Antón A, Montalar J, Carulla J, Jara C, Batista N, Camps C, Cassinello J, Sanz-Ortiz J, Díaz-Rubio E, Martínez C et al (2012) Pain in clinical oncology: patient satisfaction with management of cancer pain. Eur J Pain 16(3):381–389
pubmed: 22337158
doi: 10.1002/j.1532-2149.2011.00036.x
Yun YH, Heo DS, Lee IG, Jeong HS, Kim HJ, Kim SY, Kim YH, Ro YJ, Yoon SS, Lee KH et al (2003) Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manage 25(5):430–437
pubmed: 12727040
doi: 10.1016/S0885-3924(03)00103-9
Prandi C, Garrino L, Mastromarino P, Torino F, Vellone E, Peruselli C, Alvaro R (2015) Barriers in the management of cancer-related pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy. Ann Ist Super Sanita 51(1):71–78
pubmed: 25857388
Nardin S, Mora E, Varughese FM, D’Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A (2020) Breast cancer survivorship, quality of life, and late toxicities. Front Oncol 10:864
pubmed: 32612947
pmcid: 7308500
doi: 10.3389/fonc.2020.00864
Cooney MA, Culleton-Quinn E, Stokes E (2013) Current knowledge of pain after breast cancer treatment: a systematic review. Pain Manag Nurs 14(2):110–123
pubmed: 23688365
doi: 10.1016/j.pmn.2010.09.002
Juhl AA, Christiansen P, Damsgaard TE (2016) Persistent Pain after Breast Cancer Treatment: A Questionnaire-Based Study on the Prevalence, Associated Treatment Variables, and Pain Type. J Breast Cancer 19(4):447–454
pubmed: 28053634
pmcid: 5204052
doi: 10.4048/jbc.2016.19.4.447
Tinoco G, Warsch S, Glück S, Avancha K, Montero AJ (2013) Treating breast cancer in the 21st century: emerging biological therapies. J Cancer 4(2):117–132
pubmed: 23386910
pmcid: 3563073
doi: 10.7150/jca.4925
Im DD, Jambaulikar GD, Kikut A, Gale J, Weiner SG (2020) Brief pain inventory–short form: a new method for assessing pain in the emergency department. Pain Med 21(12):3263–3269
pubmed: 32918473
doi: 10.1093/pm/pnaa269
Abu Farha NH, Khatib MT, Salameh H, Zyoud SH (2017) Cancer-related post-treatment pain and its impact on health-related quality of life in breast cancer patients: a cross sectional study in Palestine. Asia Pac Fam Med 16:7
pubmed: 29200943
pmcid: 5696967
doi: 10.1186/s12930-017-0037-3
Marzouq MK, Samoudi AF, Samara A, Zyoud SH, Al-Jabi SW (2021) Exploring factors associated with pain in hemodialysis patients: a multicenter cross-sectional study from Palestine. BMC Nephrol 22(1):96
pubmed: 33731036
pmcid: 7972237
doi: 10.1186/s12882-021-02305-1
Mhesin D, Nazzal H, Amerah J, Azamtta M, Ismail Y, Daralammouri Y, Abdalla MA, Jaber MM, Koni AA, Zyoud SH (2022) Prevalence of pain and its association with quality of life of patients with heart failure in a developing country: findings from a multicenter cross-sectional study. BMC Cardiovasc Disord 22(1):426
pubmed: 36171539
pmcid: 9516499
doi: 10.1186/s12872-022-02864-7
Samoudi AF, Marzouq MK, Samara AM, Zyoud SH, Al-Jabi SW (2021) The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine. Health Qual Life Outcomes 19(1):39
pubmed: 33531025
pmcid: 7852263
doi: 10.1186/s12955-021-01686-z
Shalhoub M, Anaya M, Deek S, Zaben AH, Abdalla MA, Jaber MM, Koni AA, Zyoud SH (2022) The impact of pain on quality of life in patients with osteoarthritis: a cross-sectional study from Palestine. BMC Musculoskelet Disord 23(1):248
pubmed: 35287651
pmcid: 8919689
doi: 10.1186/s12891-022-05207-x
Atkinson MJ, Kumar R, Cappelleri JC, Hass SL (2005) Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers, vol 8. Elsevier, pp S9–S24
Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:1–13
doi: 10.1186/1477-7525-2-1
Abu Hamdeh H, Al-Jabi SW, Koni A, Zyoud SH (2022) Health-related quality of life and treatment satisfaction in Palestinians with rheumatoid arthritis: a cross-sectional study. BMC Rheumatol 6(1):19
pubmed: 35382894
pmcid: 8985358
doi: 10.1186/s41927-022-00251-5
Sweileh WM, Ihbesheh MS, Jarar IS, Sawalha AF, Abu Taha AS, Zyoud SH, Morisky DE (2011) Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimens. Curr Drug Saf 6(5):285–290
pubmed: 22424535
doi: 10.2174/157488611798918755
Zyoud SH, Al-Jabi SW, Sweileh WM, Arandi DA, Dabeek SA, Esawi HH, Atyeh RH, Abu-Ali HA, Sleet YI, Abd-Alfatah BM et al (2015) Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: Findings from a cross-sectional study. J Clin Transl Endocrinol 2(2):66–71
pubmed: 29159112
pmcid: 5685049
Zyoud SH, Al-Jabi SW, Sweileh WM, Morisky DE (2013) Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes 11:191
pubmed: 24195638
pmcid: 4228307
doi: 10.1186/1477-7525-11-191
American Society of Clinical Oncology (2015) Breast cancer treatment guidelines. https://www.asco.org/practice-patients/guidelines/breast-cancer . Accessed 26 Feb 2022
Berghuis AMSKH, Terstappen LWMM, Sleijfer S, IJzerman MJ (2017) Estimating The Drug Treatment Cost of Breast Cancer. Value Health 20(9):A430–A431
doi: 10.1016/j.jval.2017.08.189
Kharroubi AT, Abu Seir RY (2016) Cancer Care in Palestine. In: Silbermann M (ed) Cancer Care in Countries and Societies in Transition: Individualized Care in, Focus. Springer International Publishing, Cham, pp 77–97
doi: 10.1007/978-3-319-22912-6_6
Swieboda P, Filip R, Prystupa A, Drozd M (2013) Assessment of pain: types, mechanism and treatment. Ann Agric Environ Med 1:2–7
McCarberg BH, Nicholson BD, Todd KH, Palmer T, Penles L (2008) The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther 15(4):312–320
pubmed: 18645331
doi: 10.1097/MJT.0b013e31818164f2
Mistiaen P, van Osch M, van Vliet L, Howick J, Bishop FL, Di Blasi Z, Bensing J, van Dulmen S (2016) The effect of patient-practitioner communication on pain: a systematic review. Eur J Pain 20(5):675–688
pubmed: 26492629
doi: 10.1002/ejp.797
Wang K, Yee C, Tam S, Drost L, Chan S, Zaki P, Rico V, Ariello K, Dasios M, Lam H et al (2018) Prevalence of pain in patients with breast cancer post-treatment: A systematic review. Breast 42:113–127
pubmed: 30243159
doi: 10.1016/j.breast.2018.08.105
Barclay S, Todd C, Grande G, Lipscombe J (2002) Controlling Cancer Pain in Primary Care: The Prescribing Habits and Knowledge Base of General Practitioners. J Pain Symptom Manage 23(5):383–392
pubmed: 12007756
doi: 10.1016/S0885-3924(02)00389-5
Hagedorn JM (2022) World Health Organization Analgesic Ladder. In: Banik RK (eds) Anesthesiology In-Training Exam Review. Springer, Cham
Eljedi A, Nofal M (2014) Health-related quality of life and its influencing factors among breast cancer Patients in Palestine. J Womens Health, Issues Care 3(5)
Stylianou C, Kalemikerakis I, Vastardi M, Kavga A, Margari N, Dokoutsidou E, Konstantinidis T, Govina O (2021) Assessment of oncology patients’ satisfaction from intravenous chemotherapy. J buon 26(5):2176–2182
pubmed: 34761632
Heydarnejad MS, Hassanpour DA, Solati DK (2011) Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci 11(2):266–270
pubmed: 21857860
pmcid: 3158510
Dehkordi A, Heydarnejad MS, Fatehi D (2009) Quality of Life in Cancer Patients undergoing Chemotherapy. Oman Med J 24(3):204–207
pubmed: 22224186
pmcid: 3251183
Lewandowska A, Rudzki G, Lewandowski T, Próchnicki M, Rudzki S, Laskowska B, Brudniak J (2020) Quality of Life of Cancer Patients Treated with Chemotherapy. Int J Environ Res Public Health 17(19):6938
pubmed: 32977386
pmcid: 7579212
doi: 10.3390/ijerph17196938
Tabata A, Kanai M, Horimatsu T, Tsuboyama T, Matsushima K, Kato T (2018) Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study. Support Care Cancer 26(7):2397–2405
pubmed: 29423680
pmcid: 5982431
doi: 10.1007/s00520-018-4070-z
Kayl AE, Meyers CA (2006) Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol 18(1):24–28
pubmed: 16493256
doi: 10.1097/01.gco.0000192996.20040.24
Anampa J, Makower D, Sparano JA (2015) Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med 13(1):195
pubmed: 26278220
pmcid: 4538915
doi: 10.1186/s12916-015-0439-8
Chen ML, Yu CT, Yang CH (2008) Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer 62(3):391–400
pubmed: 18468718
doi: 10.1016/j.lungcan.2008.03.016
Taira N, Sawaki M, Uemura Y, Saito T, Baba S, Kobayashi K, Kawashima H, Tsuneizumi M, Sagawa N, Bando H et al (2021) Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. J Clin Oncol 39(22):2452–2462
pubmed: 33835842
doi: 10.1200/JCO.20.02751
McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, Fahey TP (2008) Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 99(11):1763–1768
pubmed: 18985046
pmcid: 2600703
doi: 10.1038/sj.bjc.6604758
Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM (2007) Patient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use. Med Care 45(5):431–439
pubmed: 17446829
doi: 10.1097/01.mlr.0000257193.10760.7f
Wynne C, Harvey V, Schwabe C, Waaka D, McIntyre C, Bittner B (2013) Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer. J Clin Pharmacol 53(2):192–201
pubmed: 23436264
doi: 10.1177/0091270012436560
Locke KW, Maneval DC, LaBarre MJ (2019) ENHANZE(®) drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20. Drug Deliv 26(1):98–106
pubmed: 30744432
pmcid: 6394283
doi: 10.1080/10717544.2018.1551442
Jackisch C, Stroyakovskiy D, Pivot X, Ahn JS, Melichar B, Chen SC, Meyenberg C, Al-Sakaff N, Heinzmann D, Hegg R (2019) Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial. JAMA Oncol 5(5):e190339
pubmed: 30998824
pmcid: 6512301
doi: 10.1001/jamaoncol.2019.0339
Rojas L, Muñiz S, Medina L, Peña J, Acevedo F, Pinto MP, Sanchez C (2020) Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer. PLoS ONE 15(2):e0227961
pubmed: 32023267
pmcid: 7001963
doi: 10.1371/journal.pone.0227961